Loading...

457 posters, 2 videos, 2 audios, 8 topics, 45 sessions, 401 authors, 265 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

49th Annual Regional Anesthesiology and Acute Pain Medicine Meeting

March 21-23, 2024 | The Hilton Bayfront San Diego | San Diego, California

49th Annual Regional Anesthesiology and Acute Pain Medicine Meeting banner

5316

PHARMACODYNAMIC PROFILE OF INTRATHECAL HYPOBARIC LOCAL ANAESTHETICS. A PROSPECTIVE OBSERVATIONAL STUDY.

Poster Presenter

Wendy Wang

Authors

Wendy Wang

Part of Topic

Scientific Abstracts > Regional Anesthesia

The Anesthetic and Recovery Profiles of Low-dose Hypobaric Mepivacaine
and Bupivacaine for Spinal Anesthesia in Total Hip and Knee Arthroplasty

There is increasing emphasis in modern orthopedic practice on same-day mobilization and
hospital discharge following total joint arthroplasty.
• PROBLEM: large doses of isobaric local anesthetic (LA) are often used to achieve adequate
block height ⇨ can cause unnecessarily prolonged sensory and motor blockade.
• PROPOSED SOLUTION: administration of hypobaric LA allows manipulation of intrathecal
distribution to achieve adequate block height independent of administered dose.

 

Unlike isobaric LA, hypobaric LA solutions have highly predictable distribution within the CSF
with appropriate positioning ⇨ enables use of lower doses and faster recovery without
sacrificing block onset and height.
• Both hypobaric solutions:
o Provide a rapid onset of block to T10 and L1 ⇨ shortens time to surgical readiness which
may enhance operating room efficiency;
o Provide satisfactory surgical anesthesia regardless of level of injection ⇨ useful when lower
interspaces like L5-S1 are the only accessible space;
o Have reliable onset and recovery profiles ⇨ can be ideal for fast-track pathways prioritizing
early mobilization or same-day discharge.

49th Annual Regional Anesthesiology and Acute Pain Medicine Meeting » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.